ASP Isotopes Inc ASPI.OQ reported a quarterly adjusted loss of $1.03 per share for the quarter ended June 30. The lone analyst forecast for the quarter was for a loss of 11 cents per share.
Revenue was $1.20 million; analysts expected $1.60 million.
ASP Isotopes Inc's reported EPS for the quarter was a loss of $1.03.
ASP Isotopes Inc shares had risen by 26.5% this quarter and gained 105.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 120% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for ASP Isotopes Inc is $11.00, about 15.4% above its last closing price of $9.31
This summary was machine generated from LSEG data August 18 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)